Pure Global

Detection of Novel Coronavirus 2019-nCoV/SARS-CoV-2 from clinical samples - India CDSCO Medical Device Registration

Detection of Novel Coronavirus 2019-nCoV/SARS-CoV-2 from clinical samples is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000021_9becee6f3efe45cb9ecf50f64c58023a_a6c646b4f839b02676d62698bfe2433b. This device is marketed under the brand name Multigene-Multiplex Single tube format. The license holder is Mylab Discovery S0lutions Pvt. Ltd, and it is classified as Device Class Class C. The approving authority is Central Drug Standards Control Organization, West Zone.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Detection of Novel Coronavirus 2019-nCoV/SARS-CoV-2 from clinical samples
UID: MFG/IVD/2020/000021_9becee6f3efe45cb9ecf50f64c58023a_a6c646b4f839b02676d62698bfe2433b

Brand Name

Multigene-Multiplex Single tube format

Device Class

Class C

Approving Authority

Central Drug Standards Control Organization, West Zone

Product Information

Detection of 2019-Novel Coronavirus/SARS-CoV-2 in respiratory specimens and sera

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing